{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:57:42Z","timestamp":1784289462909,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.jaad.2004.01.051","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T23:13:32Z","timestamp":1096067612000},"page":"515-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis"],"prefix":"10.1016","volume":"51","author":[{"given":"Steven","family":"Kempers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boguniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jarratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pariser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Stiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Chon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Wisseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.01.051_BIB1","series-title":"The Challenge of Dermato-epidemiology","first-page":"131","article-title":"Inflammatory skin diseases I: Atopic dermatitis","author":"Williams","year":"1997"},{"key":"10.1016\/j.jaad.2004.01.051_BIB2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0190-9622(86)70198-9","article-title":"Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample","volume":"15","author":"Larsen","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.01.051_BIB3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0091-6749(99)70536-1","article-title":"Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood","volume":"103","author":"Williams","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2004.01.051_BIB4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mjd.2000.107773","article-title":"The prevalence of atopic dermatitis in Oregon schoolchildren","volume":"43","author":"Laughter","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.01.051_BIB5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1365-2133.1999.02661.x","article-title":"An assessment of anxiety and dermatology life quality in patients with atopic dermatitis","volume":"140","author":"Linnet","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.01.051_BIB6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.18553\/jmcp.2002.8.5.333","article-title":"The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization","volume":"8","author":"Fivenson","year":"2002","journal-title":"J Managed Care Pharm"},{"key":"10.1016\/j.jaad.2004.01.051_BIB7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.2000.03473.x","article-title":"Topical corticosteroid phobia in patients with atopic eczema","volume":"142","author":"Charman","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.01.051_BIB8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1523-1747.2003.12331.x","article-title":"Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporin A","volume":"121","author":"Meingassner","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2004.01.051_BIB9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/sder.2001.29066","article-title":"Pimecrolimus (Elidel, SDZ ASM 981)\u2014Preclinical pharmacological profile and skin selectivity","volume":"20","author":"Stuetz","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2004.01.051_BIB10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00008480-200208000-00010","article-title":"Topical immunomodulators for atopic dermatitis","volume":"14","author":"Bernard","year":"2002","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jaad.2004.01.051_BIB11","first-page":"225","article-title":"Estimation of body surface area from height and weight","volume":"54","author":"Gehan","year":"1970","journal-title":"Cancer Chemother Reps"},{"key":"10.1016\/j.jaad.2004.01.051_BIB12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.2000.03473.x","article-title":"Topical corticosteroid phobia in patients with atopic eczema","volume":"142","author":"Charman","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.01.051_BIB13","first-page":"197","article-title":"A method for appraising the stinging capacity of topically applied substances","volume":"28","author":"Frosch","year":"1977","journal-title":"J Soc Cosmet Chem"},{"key":"10.1016\/j.jaad.2004.01.051_BIB14","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1542\/peds.110.1.e2","article-title":"Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children","volume":"110","author":"Wahn","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2004.01.051_BIB15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mai.2002.121831","article-title":"Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis","volume":"109","author":"Reitamo","year":"2002","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204005511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204005511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:34:38Z","timestamp":1759268078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204005511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0190962204005511"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.01.051","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.01.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}